{"name":"Eisbach Bio GmbH","slug":"eisbach-bio-gmbh","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPbWtQY0FyVTFzS2FZc3RxS09DMFhSWjdmS3UzYkFabTZYWlNOTEw0bzNBUG1tZW5CQ1FFcmFRQW1uTF84blZKa050cUluVWJWZDM3UldwN0ppNVRtc2VnZjdpN0pMQnA1NkNXU0V6YWhlVmh6NWRrWV9rbFdGWDE2VjUtSnprNWJQcm9SS1NsUmxJeTNLS08xSTRUN2dBdzJ0a2tnUW9B?oc=5","date":"2024-05-07","type":"pipeline","source":"BioWorld News","summary":"IND clearance for Eisbach’s allosteric ALC1 inhibitor EIS-12656 - BioWorld News","headline":"IND clearance for Eisbach’s allosteric ALC1 inhibitor EIS-12656","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxNRTVZYUFlNlE5bmZIQnhXTWlobzJmWGpKUXFZZmNCdmdBV2o1QzQybkZzTEZUZ1Z2QVUyYl8tTGdwUGY1cms5bGtVNEx1aDVHemlybzJfUWNoNXhTekxKT0lVMHBrQVZYUUR5bi12NlZLQUdOSkFBZUJpeHl5N0NqS2t0ckRJWlAxVnZMOGp1VGhTVDltaWJ1U3RGQXdTeFFRa3BXVUZsRzcybEVVZTdLdzRMaXdITUk0ZWxIZmV4bUJrT0hFTFVkcWY3SEpUZXM?oc=5","date":"2024-03-22","type":"trial","source":"BioWorld News","summary":"Eisbach receives investment for first-in-human study of EIS-12656 for refractory solid tumors - BioWorld News","headline":"Eisbach receives investment for first-in-human study of EIS-12656 for refractory solid tumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNR2NEczNLSl9lVGRoSEgyRm8wbWVDOU03dER1aVVCR3dMMHdLUzNPZHpCdzJzX1FCUzBvUkFHOXFZQlFsVEdMclFuZnRPcFdaS3lWSExockJSQ2g4cDR0WHhleG5wNERhUUEzSDlILXJCYUFSWFFHU3RtMk94cWJjRGJDdFJqX2JCS3c?oc=5","date":"2022-09-25","type":"pipeline","source":"EU-Startups","summary":"37 Top Biotechnology Startups and Companies in Munich - EU-Startups","headline":"37 Top Biotechnology Startups and Companies in Munich - EU","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxOVHlIOFdRZGstejFxQTA5OTM5UmZRdmVXRXZiT3VyTEYxQ2pFaE5xQTI3MmZxTkhPZWdqWVM2Y25URGZHVlBDZFo2WkRZdUxnSklta2ZvMjlsZVVvSWxUaVBLQW1SblppVVQxRkQwYlNNajJka1p4ZW1hc3V3V2ZOMklKdHdmeFJG?oc=5","date":"2022-01-19","type":"pipeline","source":"BioSpace","summary":"Global Roundup: UCB Snaps Up Rare Disease Company Zogenix - BioSpace","headline":"Global Roundup: UCB Snaps Up Rare Disease Company Zogenix","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}